IMMUNOTOXIN-BASED TARGETED THERAPY FOR CANCER
Application
US20260098097A1
Kind: A1
Apr 09, 2026
Inventors
Zhirui Wang, Zhaohui Wang, Bradley Haverkos
Abstract
Methods of treating various types of cancer, including cutaneous T-cell lymphoma, involve administering a therapeutically effective amount of a pharmaceutical composition containing a genetically engineered C-C motif chemokine receptor 4 bispecific immunotoxin, alone, or in combination with one or more additional therapeutic agents, such as a pharmaceutical composition containing an antibody-drug conjugate.
CPC Classifications
C07K 16/2866
A61K 39/3955
A61K 47/68031
A61K 47/6849
A61P 35/00
C07K 14/55
A61K 2039/505
C07K 2317/622
C07K 2317/73
C07K 2317/92
C07K 2319/55
Filing Date
2023-12-29
Application No.
19140326